Navigation Links
Crisis Exemption Granted to Market Avipel(R) Corn Seed Treatment in Louisiana
Date:2/27/2009

NEW CASTLE, Del., Feb. 27 /PRNewswire/ -- Arkion(R) Life Sciences has received a Section 18 Crisis Exemption to market Avipel(R) Corn Seed Treatment in Louisiana effective March 1, 2009. The EPA approval means that Louisiana farmers can use Avipel(R) to protect field and sweet corn from marauding blackbirds and grackles for the 2009 planting season. Formerly known as Avitec, Avipel(R) is applied to corn seed before planting and effectively stops birds from damaging crops by eating the newly planted seeds.

This is the first year Avipel(R) has received approval in Louisiana. The product is non-lethal to birds and has been shown to be highly effective in protecting corn seed from birds in over four years of use in states with particular bird problems such as Mississippi, Michigan, Minnesota, South Dakota and Wisconsin. Information about approved uses and labels may be found at the Arkion(R) Life Sciences web site: www.ArkionLS.com.

According to Ken Ballinger (VP, Airepel(R)), Arkion(R) Life Sciences has been a pioneer in the development and commercialization of several formulations of bird repellent and bird management technologies. Arkion's patented formulations of anthraquinone have been effectively repelling geese with FlightControl(R) Plus and repelling birds from structures through the Airepel(R) Humane Bird Management business.

Arkion(R) Life Sciences LLC, based in New Castle, Delaware, is a technology-based company leading in the discovery, development and marketing of environmentally friendly, natural or nature identical bioactive compounds. The company has over 500 patents and patent applications worldwide around these technologies, including the area of feed preservation with N-Sure(R), and employs biotechnology to capitalize on new opportunities in the nutraceutical, pharmaceutical, animal health and agricultural markets. Arkion(R) has three major businesses: Airepel(R), supplying bird repellents which feature a non-lethal method to control where birds feed and roost; Hyperimmune eggs with markets in human and animal nutrition; and Bio-Technical Resources (Manitowoc, WI) which develops processes and products based upon fermentation technology such as glucosamine, N-acetylglucosamine and natamycin.


'/>"/>
SOURCE Arkion Life Sciences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Crisis Management PR Firms Advice to Stem Cell Agency Laundered Through Law Firm to Avoid Scrutiny
2. Countering an approaching water crisis
3. In the Midst of International Economic Crisis, VidaCura Offers a Helping Hand to Those Without Insurance
4. Life Science Labs Reacting to the Economic Crisis
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. Pharmions Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
7. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
8. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
9. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
10. Odyssey Thera Granted U.S. Patent for Animal Imaging
11. Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
Breaking Biology Technology:
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/18/2017)... SUNNYVALE, Calif. , April 18, 2017  Socionext Inc., a ... prototype of a media edge server, the M820, which features the ... face recognition software provided by Tera Probe, Inc., will be showcased ... and at the NAB show at the Las Vegas ... ...
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
Breaking Biology News(10 mins):